Product logins

Find logins to all Clarivate products below.


Type 2 Diabetes (The Market Access Environment – Current and Emerging Noninsulin Antidiabetic Agents) | Physician & Payer Forum | China | 2014

The increase in patient awareness and the longer life expectancies are driving the growth of the Chinese diabetes market. There is potentially great opportunity for multinational pharmaceutical companies seeking to penetrate the antidiabetic therapies market in China. However, many drugs that are launched in the West, such as SGLT-2 inhibitors and long-acting release GLP-1 analogues, are not yet available in China, and the most recently launched DPP-IV inhibitors and short-acting GLP-1 analogues are still optimizing uptake in this highly lucrative market. Navigating the road to reimbursement and optimizing market access are, therefore, challenging.

Related Market Assessment Reports

Report
Breast Cancer | China In-Depth | China | 2024
The breast cancer therapy market is one of the most dynamic markets in the oncology space in mainland China. Several new and emerging therapies are set to be approved for select subpopulations;…
Report
Type 2 Diabetes – Landscape & Forecast – Disease Landscape & Forecast (G7)
The type 2 diabetes (T2D) therapy market will expand through 2034, supported by polypharmacy and the growing use of effective branded therapies offering nonglycemic benefits. Although the loss of…
Report
Type 1 Diabetes – Current Treatment – Treatment Algorithms: Claims Data Analysis – Type 1 Diabetes (US)
Intensive insulin regimens have proven effective in delaying the progression of complications associated with untreated or poorly treated type 1 diabetes (T1D). Thus, insulin remains the…
Report
Psoriasis – Geographic Focus: China – Psoriasis | China In-Depth | China | 2025
Psoriasis is a chronic dermatologic condition with rising prevalence in China, particularly in urban areas where heightened awareness and improved access to care have led to higher diagnosis rates…
Report
Chronic Kidney Disease – Geographic Focus: China – Chronic Kidney Disease – China In-Depth (China)
Chronic kidney disease (CKD) is an irreversible condition requiring lifelong management. In China, CKD is notably widespread, particularly among older adults and those with chronic risk factors…